ロード中...
Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapy
The persistence of measurable residual disease (MRD) following induction chemotherapy is the single most powerful prognostic factor available to clinicians treating patients with acute myeloid leukemia (AML). How to use this information to guide subsequent therapy is complex, and influenced by the c...
保存先:
| 出版年: | Best Pract Res Clin Haematol |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6347460/ https://ncbi.nlm.nih.gov/pubmed/30466757 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2018.09.009 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|